Second ‐generation antipsychotic long‐acting injections in bipolar disorder: Systematic review and meta‐analysis

ConclusionsCurrent evidence is very limited to support the use of SGA LAIs (compared to oral medication) in bipolar disorder. Further high ‐quality studies, particularly comparing SGA LAIs with active control, are warranted.

Source: Bipolar Disorders - November 11, 2018 Category: Psychiatry Authors: Asta R. Prajapati, Jon Wilson, Fujian Song, Ian Maidment Tags: REVIEW ARTICLE Source Type: research